Monogram Health - Comprehensive Analysis Report
Summary
Monogram Health, established in 2019, delivers in-home, evidence-based care and benefit management for patients managing multiple chronic conditions. The company aims to transform healthcare delivery for those with polychronic diseases to promote healthier and more fulfilling lives. Their vision is to address systemic issues and change care delivery, particularly for individuals with chronic kidney disease. Monogram Health has shown significant organic revenue growth, reaching nearly $2.2 billion in 2023 from $4.9 million in 2020.
1. Strategic Focus & Objectives
Core Objectives
Monogram Health focuses on improving patient outcomes and quality of life while aiming to reduce medical costs across the healthcare continuum. Their objectives include early disease detection, slowing the progression of kidney disease, and addressing comorbid chronic conditions and metabolic disorders.
Specialization Areas
The company specializes in personalized care, covering areas such as nephrology, cardiology, endocrinology, pulmonology, behavioral health, and palliative care.
Target Markets
Monogram Health partners with health plans, physician practices, dialysis providers, and clinically integrated health systems to provide care for patients across 35 states, covering all insurance products.
2. Financial Overview
Funding History
Monogram Health has secured a total of $542 million across 5 funding rounds. The latest Series C round, which occurred on December 23, 2022, raised $375 million. The funds are used to support the expansion of its in-home kidney and polychronic care model, along with technology-driven clinical services. Key investors include Cigna Ventures, Humana, Memorial Hermann, Heritage Group, Pura Vida Investments, SCAN Health Plan, CVS Health Ventures, TPG Capital, Frist Cressey Ventures, and Norwest Venture Partners.
3. Product Pipeline
Monogram Health focuses on early detection of diseases and slowing the advancement of kidney disease. By using advanced technology, the company identifies chronic health issues early and finds those at high risk of getting worse. The company identifies gaps in care or medication errors, providing support to help patients manage their kidney health. This approach aims to reduce unnecessary hospital visits and prevent sudden dialysis needs, while also focusing on improving planned dialysis start rates.
4. Technology & Innovation
Technology Stack
Monogram Health employs user-friendly tools that connect patients with physicians and clinical teams, simplifying healthcare management from home. The company utilizes proprietary AI-driven algorithms and clinical order sets to address complex patient care needs. Scientifically driven and evidence-based interventions are also leveraged.
5. Leadership & Management
Executive Team
Michael Uchrin: CEO and Co-Founder
Shaminder Gupta, MD: Chief Medical Officer
Casey McKeon: Chief Operating Officer
Sam Daniel: Chief Strategy Officer
Kristy Linder, DO: Chief Clinical Officer
Greg Hicks: Chief Human Resources Officer
Shawn Verner: Chief Compliance Officer
Brian Loflin: Chief Technology Officer
Kavita Wei, MD: Vice Chief Medical Officer
Recent Leadership Changes
Greg Hicks joined Monogram Health as Chief Human Resources Officer in December 2023, after serving as The Cigna Group’s SVP & Human Resources Officer of Cigna Healthcare.
6. Competitive Analysis
Major Competitors
PromptCare
HealPros
First Home Healthcare
Strive Health
Somatus
Cricket Health
SIME Clinical AI
Neko Health
Prenosis
HealthJoy
These competitors concentrate on in-home care, chronic disease management, and technology-driven healthcare solutions.
7. Market Analysis
Market Overview
Over 35 million U.S. adults are living with chronic kidney disease, creating a sizable market. The kidney care tech and coordination market witnesses funding rounds and industry collaborations.
8. Strategic Partnerships
Millennium Physician Group: A multi-year partnership focused on improving chronic kidney disease outcomes for patients across Florida.
Memorial Hermann Health System: A partnership aimed at improving outcomes for patients with polychronic conditions.
SCAN Group: A strategic investment and agreement designed to improve care for older adults with kidney disease.
9. Operational Insights
Monogram Health differentiates itself with evidence-based care, a patient-centric approach, and technology-driven solutions. Their in-home care model and multi-specialty provider teams enhance access to affordable care and drive better health outcomes. Monogram Health operates a full-risk platform and achieves savings and improved performance of high-quality patient outcomes. The company’s care model is personalized to each patient and built for scale.
10. Future Outlook
Strategic Roadmap
Monogram Health is focused on continuing the rapid national deployment of its care delivery model and clinical services. The company aims to expand its clinical infrastructure and workforce, invest in the latest technology, and develop industry-leading AI algorithms. The company anticipates revenues of over $3 billion in 2024. Monogram Health was recognized as the Fastest Growing Company in the Nashville Metro Area by the Nashville Business Journal and the 7th Fastest Growing Company in the United States by Inc.
